RetinalGenix Technologies (RTGN) Assets Average (2021 - 2026)
RetinalGenix Technologies (RTGN) reported Assets Average of $13423.0 for Q1 2026, little changed on a YoY basis from $13438.5 in Q1 2025, and down 4.27% sequentially from $14021.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Assets Average (2021 - 2026) Analysis & Trends
RetinalGenix Technologies (RTGN) has 6 years of Assets Average data on file, last reported at $13423.0 in Q1 2026.
- For the quarter ending Q1 2026, Assets Average changed 0.12% year-over-year to $13423.0; the trailing twelve-month figure through Mar 2026 stood at $13423.0 (changed 0.12% YoY), and the FY2025 full-year result was $17993.5, up 138.29% from the prior year.
- Assets Average declined to $13423.0 in Q1 2026, from $14021.0 in the prior quarter.
- In the past five years, Assets Average ranged from a high of $87936.5 in Q3 2024 to a low of $190.5 in Q4 2023.
- A 5-year average of $18356.7 and a median of $7694.5 in 2025 frame the typical range for Assets Average.
- Across the five-year window, Assets Average surged 27144.09% in 2024 and plunged 91.25% in 2025, its largest moves.
- Tracing RTGN's Assets Average over 5 years: stood at $2104.0 in 2022, then tumbled by 90.95% to $190.5 in 2023, then surged by 27144.09% to $51900.0 in 2024, then tumbled by 72.98% to $14021.0 in 2025, then retreated by 4.27% to $13423.0 in 2026.
- Business Quant data shows RTGN's Assets Average at $13423.0 in Q1 2026, $14021.0 in Q4 2025, and $7694.5 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 98.57 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 47.07 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 44.01 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 13.51 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 6.49 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 31.64 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 37.02 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 10.57 Bn |
| 10 | RetinalGenix Technologies | 75.02 Mn | 75.02 Mn | - | 13,423.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13,423.00 |
| Dec 31, 2025 | 14,021.00 |
| Sep 30, 2025 | 7,694.50 |
| Jun 30, 2025 | 10,159.50 |
| Mar 31, 2025 | 13,438.50 |
| Dec 31, 2024 | 51,900.00 |
| Sep 30, 2024 | 87,936.50 |
| Jun 30, 2024 | 68,768.00 |
| Mar 31, 2024 | 25,336.50 |
| Dec 31, 2023 | 190.50 |
| Sep 30, 2023 | 1,172.00 |
| Jun 30, 2023 | 4,910.00 |
| Mar 31, 2023 | 3,997.50 |
| Dec 31, 2022 | 2,104.00 |
| Sep 30, 2022 | 1,970.50 |
| Jun 30, 2022 | 1,291.00 |
| Mar 31, 2022 | 3,751.00 |
| Dec 31, 2021 | 20,762.50 |